4 research outputs found

    Analysis of methods of air quality assessment. Applications in Estonia

    Get PDF
    http://www.ester.ee/record=b1733276*es

    The effect of electric field on the deposition of radon daughters

    Get PDF

    Health impact assessment of particulate pollution in Tallinn using fine spatial resolution and modeling techniques

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Health impact assessments (HIA) use information on exposure, baseline mortality/morbidity and exposure-response functions from epidemiological studies in order to quantify the health impacts of existing situations and/or alternative scenarios. The aim of this study was to improve HIA methods for air pollution studies in situations where exposures can be estimated using GIS with high spatial resolution and dispersion modeling approaches.</p> <p>Methods</p> <p>Tallinn was divided into 84 sections according to neighborhoods, with a total population of approx. 390 000 persons. Actual baseline rates for total mortality and hospitalization with cardiovascular and respiratory diagnosis were identified. The exposure to fine particles (PM<sub>2.5</sub>) from local emissions was defined as the modeled annual levels. The model validation and morbidity assessment were based on 2006 PM<sub>10 </sub>or PM<sub>2.5 </sub>levels at 3 monitoring stations. The exposure-response coefficients used were for total mortality 6.2% (95% CI 1.6–11%) per 10 μg/m<sup>3 </sup>increase of annual mean PM<sub>2.5 </sub>concentration and for the assessment of respiratory and cardiovascular hospitalizations 1.14% (95% CI 0.62–1.67%) and 0.73% (95% CI 0.47–0.93%) per 10 μg/m<sup>3 </sup>increase of PM<sub>10</sub>. The direct costs related to morbidity were calculated according to hospital treatment expenses in 2005 and the cost of premature deaths using the concept of Value of Life Year (VOLY).</p> <p>Results</p> <p>The annual population-weighted-modeled exposure to locally emitted PM<sub>2.5 </sub>in Tallinn was 11.6 μg/m<sup>3</sup>. Our analysis showed that it corresponds to 296 (95% CI 76528) premature deaths resulting in 3859 (95% CI 10236636) Years of Life Lost (YLL) per year. The average decrease in life-expectancy at birth per resident of Tallinn was estimated to be 0.64 (95% CI 0.17–1.10) years. While in the polluted city centre this may reach 1.17 years, in the least polluted neighborhoods it remains between 0.1 and 0.3 years. When dividing the YLL by the number of premature deaths, the decrease in life expectancy among the actual cases is around 13 years. As for the morbidity, the short-term effects of air pollution were estimated to result in an additional 71 (95% CI 43–104) respiratory and 204 (95% CI 131–260) cardiovascular hospitalizations per year. The biggest external costs are related to the long-term effects on mortality: this is on average €150 (95% CI 40–260) million annually. In comparison, the costs of short-term air-pollution driven hospitalizations are small €0.3 (95% CI 0.2–0.4) million.</p> <p>Conclusion</p> <p>Sectioning the city for analysis and using GIS systems can help to improve the accuracy of air pollution health impact estimations, especially in study areas with poor air pollution monitoring data but available dispersion models.</p

    Basket-ball : l'enseignement de l'arbitrage en sports collectifs dans le cadre scolaire

    Get PDF
    Peened osakesed välisõhus mõjutavad olulisel määral inimeste tervist. Neid hingatakse sügavale hingamisteedesse ning koos seotud raskmetallide, orgaaniliste ja muude keemiliste ühenditega põhjustavad osakesed erinevate mehhanismide koostoimel eeskätt põletikulisi protsesse. Käesoleva uuringu käigus tehtud tervisemõjude hinnang näitas, et peened osakesed välisõhus põhjustavad viies suuremas Eesti linnas kokku 462 (95% CI 120–815) varajast surma aastas, mis avaldub 6034 (95% CI 1583–10309) kaotatud eluaastana. Keskmine oodatava eluea vähenemine on 0,63 (95% CI 0,16–1,08) aastat, mis enam saastunud kesklinnas on veidi üle aasta ning äärelinnas mõni kuu. Varajastele surmadele lisandub 231 (95% CI 145–306) hingamisteede ja 338 (95% CI 205–454) südame-veresoonkonnakaebusega hospitaliseerimise juhtu aastas. Kõik see tekitab tervishoiu süsteemile olulise kulu, mille suurus jääb 3–5,5 miljardi krooni vahele. Eesti Arst 2010; 89(4):242−25
    corecore